Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Annual Reports & Annual General Meetings
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » BioDiem Releases Half Year Results
BioDiem Releases Half Year Results
March 20, 2019 •
Category
•
Author Name
BioDiem Half Year Results – 31 December 2018
Latest News
Company Update and EOFY 2019 Information
July 12, 2019
Company Update and EOFY 2019 Information
Read More
BioDiem Releases Half Year Results
March 20, 2019
BioDiem Half Year Results – 31 December 2018
Read More
